NASDAQ:SXTC
China SXT Pharmaceuticals, Inc.
- Stock
Last Close
0.65
25/09 14:37
Market Cap
778.80K
Beta: 0.73
Volume Today
30.45K
Avg: 502.62K
PE Ratio
−0.31
PFCF: 87.82
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.19M - | 1.41M 18.29% | 1.11M 21.31% | 876.23K 21.05% | 938.61K 7.12% | 774.39K 17.50% | 670.51K 13.42% | ||
average payables | 1.84M - | 2.05M 11.46% | 1.81M 11.39% | 1.70M 6.31% | 1.47M 13.51% | 1.43M 2.67% | 1.33M 7.09% | ||
average receivables | 3.56M - | 3.78M 6.21% | 7.45M 97.41% | 9.21M 23.51% | 6.65M 27.82% | 3.55M 46.58% | 1.46M 58.85% | ||
book value per share | 0.31 - | 0.55 77.36% | 2.16 290.34% | 30.41 1,307.99% | 22.18 27.07% | 15.80 28.79% | 14.13 10.55% | 16.06 13.66% | |
capex per share | -0.03 - | -0.18 463.97% | -0.12 32.96% | -1.32 1,008.84% | -0.13 90.17% | -0.06 53.52% | -0.07 13.11% | 0.01 111.98% | |
capex to depreciation | -1.88 - | -8.12 332.34% | -3.37 58.46% | -1.23 63.66% | -0.27 78.02% | -0.20 27.51% | -0.28 44.69% | 0.03 112.30% | |
capex to operating cash flow | -0.64 - | -0.55 13.93% | -2.55 366.12% | -0.44 82.93% | 0.07 116.24% | -0.23 429.57% | 0.88 475.79% | -0.00 100.42% | |
capex to revenue | -0.04 - | -0.15 292.22% | -0.09 41.88% | -0.08 9.46% | -0.02 75.28% | -0.02 23.30% | -0.04 49.29% | 0.00 110.22% | |
cash per share | 0.01 - | 0.09 754.43% | 1.78 1,781.86% | 23.57 1,227.62% | 18.53 21.40% | 14.93 19.42% | 16.70 11.88% | 13.92 16.65% | |
days of inventory on hand | 126.54 - | 150.74 19.13% | 201.77 33.86% | 132.54 34.31% | 161.91 22.16% | 274.98 69.83% | 125.47 54.37% | 215.03 71.37% | |
days payables outstanding | 179.63 - | 242.88 35.21% | 256.27 5.51% | 288.18 12.45% | 274.30 4.82% | 400.55 46.03% | 325.43 18.76% | 339.77 4.41% | |
days sales outstanding | 285.63 - | 171.12 40.09% | 221.84 29.65% | 752.83 239.35% | 593.38 21.18% | 775.01 30.61% | 291.61 62.37% | 254.83 12.61% | |
debt to assets | 0.66 - | 0.57 13.35% | 0.36 36.21% | 0.57 55.62% | 0.54 5.08% | 0.51 5.13% | 0.13 75.09% | 0.11 15.98% | |
debt to equity | 1.93 - | 1.33 31.12% | 0.57 56.95% | 1.31 128.40% | 1.16 11.00% | 1.04 10.48% | 0.26 75.47% | 0.18 30.66% | |
dividend yield | |||||||||
earnings yield | 0.00 - | 0.00 0.21% | 0.00 30.75% | -0.74 130,523.82% | -0.10 86.03% | -0.99 849.19% | -0.81 18.28% | -2.15 167.30% | |
enterprise value | 2.73B - | 2.73B 0.02% | 2.69B 1.19% | 13.29M 99.51% | 13.19M 0.73% | -7.66M 158.04% | -6.24M 18.49% | -7.99M 28.05% | |
enterprise value over ebitda | 1.62K - | 1.55K 4.39% | 1.37K 11.78% | 2.88 99.79% | -7.12 347.49% | 1.57 122.07% | 1.16 25.91% | 4.23 263.14% | |
ev to operating cash flow | 9.30K - | 1.42K 84.74% | 11.26K 693.23% | 14.22 99.87% | -10.02 170.44% | -28.53 184.81% | 77.27 370.79% | 4.14 94.64% | |
ev to sales | 558.58 - | 388.41 30.47% | 384.18 1.09% | 2.57 99.33% | 2.76 7.26% | -2.94 206.56% | -3.16 7.58% | -4.14 30.91% | |
free cash flow per share | 0.02 - | 0.15 714.58% | -0.07 149.26% | 1.71 2,466.32% | -1.96 214.78% | 0.20 110.10% | -0.15 173.59% | -2.23 1,431.68% | |
free cash flow yield | 0.00 - | 0.00 714.58% | -0.00 143.04% | 0.04 27,857.08% | -0.05 239.75% | 0.04 166.40% | -0.02 158.12% | -1.34 6,441.94% | |
graham net net | -0.03 - | -0.10 194.35% | 1.29 1,382.25% | 11.06 757.96% | 1.39 87.41% | 2.94 111.07% | 3.80 29.36% | 4.95 30.26% | |
graham number | 1.18 - | 1.58 33.31% | 3.81 141.70% | 150.92 3,856.65% | 43.66 71.07% | 44.28 1.42% | 42.60 3.80% | 35.93 15.66% | |
income quality | 0.25 - | 1.62 553.91% | 0.16 90.39% | -0.09 158.44% | 0.48 627.54% | -0.05 109.76% | 0.01 129.09% | 0.62 4,472.85% | |
intangibles to total assets | 0.01 - | 0.01 4.94% | 0.00 55.86% | 0.00 34.05% | 0.00 42.52% | 0.00 12.84% | 0.00 18.39% | 0.00 12.41% | |
interest coverage | -2.09K - | -342.26 83.64% | 0.29 100.09% | -2.95 1,111.64% | -23.78 704.90% | -11.76 50.53% | -3.84 67.32% | ||
interest debt per share | 0.05 - | 0.06 27.19% | 0.06 10.56% | 69.23 119,476.30% | 1.09 98.42% | 2.18 99.08% | 4.07 86.94% | 3.47 14.66% | |
inventory turnover | 2.88 - | 2.42 16.06% | 1.81 25.29% | 2.75 52.24% | 2.25 18.14% | 1.33 41.12% | 2.91 119.15% | 1.70 41.65% | |
invested capital | 0.16 - | 0.12 28.14% | 0.03 76.74% | 0.72 2,523.07% | 0.00 99.62% | 0.12 4,480.62% | 0.26 105.24% | 5.92M 2,313,243,378.50% | |
market cap | 2.73B - | 2.73B 0% | 2.70B 0.87% | 13.85M 99.49% | 26.48M 91.18% | 5.82M 78.01% | 7.37M 26.61% | 1.44M 80.47% | |
net current asset value | 1.33M - | 1.73M 30.44% | 9.23M 433.22% | 7.34M 20.48% | 4.65M 36.65% | 5.33M 14.70% | 4.66M 12.60% | 5.04M 8.12% | |
net debt to ebitda | 0.14 - | -0.10 170.78% | -4.49 4,400.48% | -0.12 97.28% | 7.18 5,983.66% | 2.77 61.44% | 2.54 8.20% | 4.99 96.47% | |
net income per share | 0.20 - | 0.20 0.21% | 0.30 49.66% | -33.28 11,218.78% | -3.82 88.52% | -5.52 44.44% | -5.71 3.46% | -3.57 37.42% | |
operating cash flow per share | 0.05 - | 0.32 555.25% | 0.05 85.62% | 3.02 6,397.61% | -1.83 160.54% | 0.26 114.10% | -0.08 130.10% | -2.22 2,761.83% | |
payables turnover | 2.03 - | 1.50 26.04% | 1.42 5.22% | 1.27 11.07% | 1.33 5.06% | 0.91 31.52% | 1.12 23.09% | 1.07 4.22% | |
receivables turnover | 1.28 - | 2.13 66.92% | 1.65 22.87% | 0.48 70.53% | 0.62 26.87% | 0.47 23.44% | 1.25 165.77% | 1.43 14.43% | |
research and ddevelopement to revenue | 0.10 - | ||||||||
return on tangible assets | 0.22 - | 0.16 28.90% | 0.09 43.44% | -0.48 637.42% | -0.08 83.24% | -0.17 114.92% | -0.20 17.41% | -0.13 33.29% | |
revenue per share | 0.82 - | 1.18 43.79% | 1.36 15.35% | 16.70 1,124.71% | 6.64 60.24% | 2.50 62.31% | 1.90 24.23% | 2.22 17.24% | |
roe | 0.64 - | 0.36 43.50% | 0.14 61.66% | -1.09 889.69% | -0.17 84.27% | -0.35 102.84% | -0.40 15.67% | -0.22 44.94% | |
roic | 0.30 - | 0.29 3.16% | -0.61 312.92% | 0.82 233.23% | -0.32 139.07% | -5.42 1,596.43% | -0.32 94.04% | -0.13 60.51% | |
sales general and administrative to revenue | 0.12 - | 0.25 117.60% | 0.41 60.80% | 0.48 17.65% | 0.72 51.41% | 2.12 193.64% | 2.86 35.08% | 1.37 52.28% | |
shareholders equity per share | 0.31 - | 0.55 77.36% | 2.16 290.34% | 30.41 1,307.99% | 22.18 27.07% | 15.80 28.79% | 14.13 10.55% | 16.06 13.66% | |
stock based compensation to revenue | 0.90 - | 0.28 68.65% | 0.18 35.09% | ||||||
tangible asset value | 1.81M - | 3.23M 78.02% | 11.05M 242.52% | 9.35M 15.35% | 15.92M 70.20% | 16.39M 2.96% | 14.66M 10.51% | 13.91M 5.13% | |
tangible book value per share | 0.31 - | 0.54 78.02% | 2.15 295.50% | 30.25 1,308.24% | 22.12 26.89% | 15.76 28.75% | 14.10 10.51% | 16.04 13.72% | |
working capital | 1.33M - | 1.73M 30.44% | 9.27M 435.63% | 7.37M 20.45% | 4.65M 36.88% | 5.33M 14.54% | 5.02M 5.74% | 5.33M 6.11% |
All numbers in USD (except ratios and percentages)